Cafepharma Today

November 29 2023 - FDA names chief scientist Bumpus as Woodcock’s successor
FDA names chief scientist Bumpus as Woodcock’s successor
FDA launches probe of malignancies linked to CAR-T therapies
FDA kicks off review of Karuna’s schizophrenia drug KarXT
Lilly puts potential $660M on the line for protein-protein interaction blockers
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Azur Sues Barr to Block Generic Form of Schizophrenia Drug
Bloomberg
Monday, August 25, 2008 - 2:00pm
tags:
AstraZeneca's Flu Campaign Season Begins
CNBC
Monday, August 25, 2008 - 1:50pm
tags:
Will FDA label regs shield pharma?
Fierce Pharma
Monday, August 25, 2008 - 11:39am
tags:
Genzyme to help pursue malaria research
Bizjournals.com
Monday, August 25, 2008 - 11:12am
tags:
Early Glance: Biotechnology companies
Yahoo/AP
Monday, August 25, 2008 - 10:56am
tags:
Amgen is poised for higher opening following approval of rare blood-clotting disorder drug
Yahoo/AP
Monday, August 25, 2008 - 9:16am
tags:
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Yahoo
Monday, August 25, 2008 - 7:48am
tags:
Glaxo's HIV-Drug Ads Draw Critics
WSJ Online
Monday, August 25, 2008 - 6:06am
tags:
Ranbaxy Falls After Dow Says India to Review Purchase
Bloomberg
Monday, August 25, 2008 - 5:56am
tags:
Nicox says Pfizer drops glaucoma drug study in Asia
Yahoo/Reuters
Monday, August 25, 2008 - 5:55am
tags:
Eisai Wins U.S. Approval to Sell Nausea Drug Aloxi in Capsules
Bloomberg
Sunday, August 24, 2008 - 10:16pm
tags:
The Long Case for Pfizer
Seeking Alpha
Sunday, August 24, 2008 - 4:00pm
tags:
Dr Reddy's plans to brand US speciality drugs
Business Standard, India
Sunday, August 24, 2008 - 10:32am
tags:
Antibody Engineering Cuts the Collateral Damage of Cancer Drugs
Wired News
Sunday, August 24, 2008 - 10:30am
tags:
New FDA labels may protect drug makers
The News Journal, DE
Sunday, August 24, 2008 - 10:23am
tags:
FDA Approves ALOXI(R) (Palonosetron HCl) Capsules For Prevention Of Acute Chemotherapy Induced Nausea And Vomiting
Medical News Today
Sunday, August 24, 2008 - 10:22am
tags:
Long Uphill Climb Continues For Genetics Firms
Yahoo/Investors Business Daily
Saturday, August 23, 2008 - 2:07pm
tags:
Don't Worry About Vytorin's Cancer Risk
Motley Fool
Saturday, August 23, 2008 - 10:47am
tags:
Salix Pharmaceuticals Sells $60 Million Of Convertible Notes
Trading Markets
Saturday, August 23, 2008 - 10:43am
tags:
GSK to provide public with more information
San Antonio Business Journal, TX
Saturday, August 23, 2008 - 10:42am
tags:

Pages

Latest CP Wire Articles

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

Latest Pharmagather Articles

Drug Channels News Roundup, November 2023: My $0.02 on Express Scripts’ Cost-Based Pricing, Mark Cuban vs. PBMs, Dual-WAC Strategies, Pharmacy Shakeout, and Adam vs. Rocky
Drug Channels
Simplify and Accelerate Benefits Verification with a Fully Integrated, Adaptable Platform
Drug Channels
Medicare Part D in 2024: Mapping Large Chains' Position in 2024’s Preferred Pharmacy Networks
Drug Channels
Drug Channels Outlook 2024 (NEW Live Video Webinar)
Drug Channels
Four Trends That Are Shaping the Future of Market Access
Drug Channels
FDA’s OPDP Issues Two New Untitled Letters
eye on fda
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies
Drug Channels
Is Your Hub Partner Missing the Therapeutic Area Expertise You Need?
Drug Channels
Drug Channels News Roundup, October 2023: CVS & Humira Biosimilars, GLP-1 G2N Bubble, 340B Abuses, Rite Aid's Endgame, Mark Cuban Update, and an Epic Meetup
Drug Channels

Latest Jobs

Principal EP Mapping Specialist - Philly Field Base
Philadelphia, PA, 19019
Boston Scientific
EP Mapping Specialist II - Boston Field based
Boston, MA, 02108
Bo
2020-2024 Undergraduates, Customer Relationship Advocate - Covington, KY
Springfield, OH, 45502
Fidelity Investments
Customer Service Representative
North Vernon, IN, 47265
Fidelity Investments

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information